Skip to main content
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Fourth in a series: Conquering the Cancer Care Continuum™
Supplements
Supplements
Related Items
Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
By
Wen Wee Ma, MBBS
RX Profiler - Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Supplements
Serious Toxicities Associated with 5-Fluorouracil and Capecitabine: A Clinical Pharmacy Perspective
By
Amber Draper, PharmD, BCOP
RX Profiler - Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Supplements
The Importance of Patient Education in the Management of Treatment-Related Toxicities: A Nurse’s Perspective
By
Melissa Hennessey Smith, MSN, AGPCNP-BC
RX Profiler - Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Supplements
Impact of the Affordable Care Act on Cancer Care
By
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Conquering the Cancer Care Continuum - Series Three: Fourth Issue
Supplements